{{Rsnum
|rsid=6493487
|Gene=CYP19A1
|Chromosome=15
|position=51221532
|Orientation=plus
|GMAF=0.2264
|Gene_s=CYP19A1
|Assembly=GRCh38
|GenomeBuild=38.1
|dbSNPBuild=141
|geno1=(A;A)
|geno2=(A;G)
|geno3=(G;G)
}}{{ population diversity
| geno1=(A;A)
| geno2=(A;G)
| geno3=(G;G)
| CEU | 64.6 | 30.1 | 5.3
| HCB | 53.3 | 36.5 | 10.2
| JPT | 56.6 | 34.5 | 8.8
| YRI | 91.8 | 8.2 | 0.0
| ASW | 78.9 | 21.1 | 0.0
| CHB | 53.3 | 36.5 | 10.2
| CHD | 43.1 | 47.7 | 9.2
| GIH | 51.5 | 41.6 | 6.9
| LWK | 88.2 | 11.8 | 0.0
| MEX | 44.8 | 44.8 | 10.3
| MKK | 82.7 | 16.7 | 0.6
| TSI | 45.1 | 43.1 | 11.8
| HapMapRevision=28
}}{{PMID Auto GWAS
  |PMID=23400010
  |Trait=Thiazide-induced adverse metabolic effects in hypertensive patients
  |Title=Genome-wide association analyses suggest NELL1 influences adverse metabolic response to HCTZ in African Americans.
  |RiskAllele=G
  |Pval=8E-6
  |OR=5.96
  |ORtxt=[3.35-8.57] mg/dL increase
  |OA=1
}}

{{on chip | 23andMe v1}}
{{on chip | 23andMe v2}}
{{on chip | 23andMe v3}}
{{on chip | 23andMe v4}}
{{on chip | Affy GenomeWide 6}}
{{on chip | Illumina Human 1M}}